English
Insider transactions
EDGARERYTECH PHARMA S.A.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-22.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
No Form 3, 4 or 5 for this issuer is in the store. The store has read filings dated 1980-01-02 to 2026-11-20; this is not a statement that none were filed.
Latest reported holdings
What each reporting owner last said they hold, as of the date shown. A transaction not yet filed is not in it.
No holding was reported in this window.
Institutional holders (Form 13F)
No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read from their tags. Earlier schedules are free text: they are read only when every cover page states a share count and a percent, and the rest are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Armistice Capital, LLC American Depositary Shares, each representing one ordinary share, nominal value €0.10 per share | 4.99 | 1,629,118 | — Filed 2023-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0001172661-23-001092 Dispute this row |
| Steven Boyd American Depositary Shares, each representing one ordinary share, nominal value €0.10 per share | 4.99 | 1,629,118 | — Filed 2023-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0001172661-23-001092 Dispute this row |
| Armistice Capital, LLC Ordinary Shares, nominal value €0.10 per share | 9.3 | 2,737,252 | — Filed 2022-02-15 | SC 13GRead from the cover page text | Open filing 0001193125-22-042390 Dispute this row |
| Steven Boyd Ordinary Shares, nominal value €0.10 per share | 9.3 | 2,737,252 | — Filed 2022-02-15 | SC 13GRead from the cover page text | Open filing 0001193125-22-042390 Dispute this row |
| Biotechnology Value Fund, L.P. Ordinary Shares, nominal value €0.10 per share | 8.8 | 2,714,807 | — Filed 2022-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0000921895-22-000535 Dispute this row |
| BVF I GP LLC Ordinary Shares, nominal value €0.10 per share | 8.8 | 2,714,807 | — Filed 2022-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0000921895-22-000535 Dispute this row |
| Biotechnology Value Fund II, L.P. Ordinary Shares, nominal value €0.10 per share | 6.4 | 1,979,682 | — Filed 2022-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0000921895-22-000535 Dispute this row |
| BVF II GP LLC Ordinary Shares, nominal value €0.10 per share | 6.4 | 1,979,682 | — Filed 2022-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0000921895-22-000535 Dispute this row |
| Biotechnology Value Trading Fund OS LP Ordinary Shares, nominal value €0.10 per share | 1.0 | 312,664 | — Filed 2022-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0000921895-22-000535 Dispute this row |
| BVF Partners OS Ltd. Ordinary Shares, nominal value €0.10 per share | 1.0 | 312,664 | — Filed 2022-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0000921895-22-000535 Dispute this row |
| BVF GP Holdings LLC Ordinary Shares, nominal value €0.10 per share | 15.1 | 4,694,489 | — Filed 2022-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0000921895-22-000535 Dispute this row |
| BVF Partners L.P. Ordinary Shares, nominal value €0.10 per share | 16.5 | 5,119,183 | — Filed 2022-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0000921895-22-000535 Dispute this row |
| BVF Inc. Ordinary Shares, nominal value €0.10 per share | 16.5 | 5,119,183 | — Filed 2022-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0000921895-22-000535 Dispute this row |
| Mark N. Lampert Ordinary Shares, nominal value €0.10 per share | 16.5 | 5,119,183 | — Filed 2022-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0000921895-22-000535 Dispute this row |
| Biotechnology Value Fund, L.P. Ordinary Shares, nominal value €0.10 per share | 10.1 | 2,144,331 | — Filed 2021-03-10 | SC 13GAmendment 1Read from the cover page text | Open filing 0000921895-21-000691 Dispute this row |
| BVF I GP LLC Ordinary Shares, nominal value €0.10 per share | 10.1 | 2,144,331 | — Filed 2021-03-10 | SC 13GAmendment 1Read from the cover page text | Open filing 0000921895-21-000691 Dispute this row |
| Biotechnology Value Fund II, L.P. Ordinary Shares, nominal value €0.10 per share | 7.5 | 1,579,621 | — Filed 2021-03-10 | SC 13GAmendment 1Read from the cover page text | Open filing 0000921895-21-000691 Dispute this row |
| BVF II GP LLC Ordinary Shares, nominal value €0.10 per share | 7.5 | 1,579,621 | — Filed 2021-03-10 | SC 13GAmendment 1Read from the cover page text | Open filing 0000921895-21-000691 Dispute this row |
| Biotechnology Value Trading Fund OS LP Ordinary Shares, nominal value €0.10 per share | 1.2 | 260,060 | — Filed 2021-03-10 | SC 13GAmendment 1Read from the cover page text | Open filing 0000921895-21-000691 Dispute this row |
| BVF Partners OS Ltd. Ordinary Shares, nominal value €0.10 per share | 1.2 | 260,060 | — Filed 2021-03-10 | SC 13GAmendment 1Read from the cover page text | Open filing 0000921895-21-000691 Dispute this row |
| BVF GP HOLDINGS LLC Ordinary Shares, nominal value €0.10 per share | 17.6 | 3,723,952 | — Filed 2021-03-10 | SC 13GAmendment 1Read from the cover page text | Open filing 0000921895-21-000691 Dispute this row |
| BVF Partners L.P. Ordinary Shares, nominal value €0.10 per share | 19.3 | 4,081,941 | — Filed 2021-03-10 | SC 13GAmendment 1Read from the cover page text | Open filing 0000921895-21-000691 Dispute this row |
| BVF Inc. Ordinary Shares, nominal value €0.10 per share | 19.3 | 4,081,941 | — Filed 2021-03-10 | SC 13GAmendment 1Read from the cover page text | Open filing 0000921895-21-000691 Dispute this row |
| Mark N. Lampert Ordinary Shares, nominal value €0.10 per share | 19.3 | 4,081,941 | — Filed 2021-03-10 | SC 13GAmendment 1Read from the cover page text | Open filing 0000921895-21-000691 Dispute this row |
| Baker Bros. Advisors LP Ordinary Shares, nominal value €0.10 per share | 17.2 | 3,085,969 | — Filed 2018-07-02 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001144204-18-037011 Dispute this row |
| Baker Bros. Advisors (GP) LLC Ordinary Shares, nominal value €0.10 per share | 17.2 | 3,085,969 | — Filed 2018-07-02 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001144204-18-037011 Dispute this row |
| Julian C. Baker Ordinary Shares, nominal value €0.10 per share | 17.2 | 3,085,969 | — Filed 2018-07-02 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001144204-18-037011 Dispute this row |
| Felix J. Baker Ordinary Shares, nominal value €0.10 per share | 17.2 | 3,085,969 | — Filed 2018-07-02 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001144204-18-037011 Dispute this row |
| Baker Bros. Advisors LP Ordinary Shares, nominal value €0.10 per share | 27.3 | 4,898,337 | — Filed 2017-11-16 | SC 13DRead from the cover page text | Open filing 0001144204-17-059720 Dispute this row |
| Baker Bros. Advisors (GP) LLC Ordinary Shares, nominal value €0.10 per share | 27.3 | 4,898,337 | — Filed 2017-11-16 | SC 13DRead from the cover page text | Open filing 0001144204-17-059720 Dispute this row |
| Julian C. Baker Ordinary Shares, nominal value €0.10 per share | 27.3 | 4,898,337 | — Filed 2017-11-16 | SC 13DRead from the cover page text | Open filing 0001144204-17-059720 Dispute this row |
| Felix J. Baker Ordinary Shares, nominal value €0.10 per share | 27.3 | 4,898,337 | — Filed 2017-11-16 | SC 13DRead from the cover page text | Open filing 0001144204-17-059720 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
3,104,499 filings read, dated 1980-01-02 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 258,595 |
| 2016 | 246,472 |
| 2017 | 244,814 |
| 2018 | 245,575 |
| 2019 | 238,619 |
| 2020 | 249,093 |
| 2021 | 274,850 |
| 2022 | 257,922 |
| 2023 | 253,676 |
| 2024 | 261,106 |
| 2025 | 235,525 |
| 2026 | 263,830 |
Filings made before the SEC required XML are listed, not extracted.